GB201600061D0 - Methotrexate sodium medicine intermediatediethanol shrink acrolein synthesis method - Google Patents
Methotrexate sodium medicine intermediatediethanol shrink acrolein synthesis methodInfo
- Publication number
- GB201600061D0 GB201600061D0 GBGB1600061.4A GB201600061A GB201600061D0 GB 201600061 D0 GB201600061 D0 GB 201600061D0 GB 201600061 A GB201600061 A GB 201600061A GB 201600061 D0 GB201600061 D0 GB 201600061D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- intermediatediethanol
- shrink
- synthesis method
- methotrexate sodium
- sodium medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- HGINCPLSRVDWNT-UHFFFAOYSA-N Acrolein Chemical compound C=CC=O HGINCPLSRVDWNT-UHFFFAOYSA-N 0.000 title 2
- 239000003814 drug Substances 0.000 title 1
- BKBBTCORRZMASO-ZOWNYOTGSA-M methotrexate monosodium Chemical compound [Na+].C=1N=C2N=C(N)N=C(N)C2=NC=1CN(C)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C([O-])=O)C=C1 BKBBTCORRZMASO-ZOWNYOTGSA-M 0.000 title 1
- 229960003058 methotrexate sodium Drugs 0.000 title 1
- 238000001308 synthesis method Methods 0.000 title 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1600061.4A GB201600061D0 (en) | 2016-01-03 | 2016-01-03 | Methotrexate sodium medicine intermediatediethanol shrink acrolein synthesis method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1600061.4A GB201600061D0 (en) | 2016-01-03 | 2016-01-03 | Methotrexate sodium medicine intermediatediethanol shrink acrolein synthesis method |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB201600061D0 true GB201600061D0 (en) | 2016-02-17 |
Family
ID=55406650
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GBGB1600061.4A Ceased GB201600061D0 (en) | 2016-01-03 | 2016-01-03 | Methotrexate sodium medicine intermediatediethanol shrink acrolein synthesis method |
Country Status (1)
| Country | Link |
|---|---|
| GB (1) | GB201600061D0 (en) |
-
2016
- 2016-01-03 GB GBGB1600061.4A patent/GB201600061D0/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL266017A (en) | Pharmaceutical compounds | |
| IL258213A (en) | Pharmaceutical compounds | |
| GB201612092D0 (en) | Pharmaceutical compounds | |
| ZA201900540B (en) | Pharmaceutical compounds | |
| GB201617758D0 (en) | Pharmaceutical compounds | |
| GB201504675D0 (en) | Pharmaceutical compounds | |
| GB201506658D0 (en) | Pharmaceutical compounds | |
| GB201519352D0 (en) | Pharmaceutical compounds | |
| GB201506660D0 (en) | Pharmaceutical compounds | |
| GB201617454D0 (en) | Pharmaceutical compounds | |
| IL258246A (en) | Pharmaceutical compounds | |
| GB201617627D0 (en) | Pharmaceutical compounds | |
| GB201612095D0 (en) | Pharmaceutical compounds | |
| GB201506933D0 (en) | Pharmaceutical compounds | |
| GB201502567D0 (en) | Pharmaceutical compounds | |
| GB201507031D0 (en) | New pharmaceutical salt forms | |
| GB201617871D0 (en) | Pharmaceutical compounds | |
| GB201600061D0 (en) | Methotrexate sodium medicine intermediatediethanol shrink acrolein synthesis method | |
| GB201615916D0 (en) | Pharmaceutical compound | |
| GB201615912D0 (en) | Pharmaceutical compound | |
| GB201600058D0 (en) | Methotrexate medicine intermediate malononitrate synthesis method | |
| GB201600050D0 (en) | lmidaclothiz pharmaceutical intermediate 2-chloro-5-methylthiazole synthesis method | |
| GB201600073D0 (en) | Nafcillin sodium medicine intermediate ethoxy-1-naphthaldehyde synthesis method | |
| GB201600029D0 (en) | Methotrexate medicine intermediate for iodotoluene synthesis method | |
| GB201705841D0 (en) | Vitamin medicine pyridine-3-formic acid synthesis method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AT | Applications terminated before publication under section 16(1) |